CONTENTS:
- Stop calling it self-medication: Tobacco smoking is not medicine [Editorial]. Vermeulen J.M., Treur J.L., Wootton R.E., Taylor G., p. 2588-2590.
- Tobacco and cannabis use in the young 'Not in Employment, Education or Training' population: A systematic review and meta-analysis. Eyraud C., Collin C., Martin P., Alberti C., Minary L., Dumas A., et al., p. 2591-2606.
- Barriers and facilitators to detoxification from opioid substitution treatment: A mixed-methods systematic review. Bagshaw A., Shah S., Olchefske I., Paterson L.M., Crawford M.J., Lingford-Hughes A., p. 2607-2619.
- Factors associated with the percentage of individuals who initiate and discontinue naltrexone as a relapse prevention pharmacotherapy in opioid use disorder: A systematic review, meta-analysis and meta-regression. Roberts E., Sanderson E., Santo T., Jr., Hickman M., Farrell M., Degenhardt L., p. 2620-2632.
- Prenatal opioid exposure, and health, social and educational outcomes for school-aged children: A systematic review. Marryat L., Gashgari D., Shinwell S., Mitchell V., Connell C., Macleod G., et al., p. 2633-2645.
- Balancing harm prevention and liberty preservation when implementing financial risk assessments for gambling in the United Kingdom: Insights from open banking data. Heirene R.M., Newall P., p. 2646-2658.
- Commentary on Heirene and Newall: The architecture of risk assessment must be co-produced. Laidler F., p. 2659-2660.
- Pioglitazone for the treatment of alcohol use disorder: A randomized controlled trial. Dieperink E., Anderson K., Dockter K., Evenson M., Thuras P., Hauser P., p. 2661-2670.
- Alcohol consumption and the risks of morbidity and mortality across 39 diseases and conditions: A population-based cohort study in Korea. Bui T.T., Kang H.Y., Lee J., Kang E., Oh J.K., p. 2671-2681.
- Impact of bariatric surgery on alcohol-use disorder and alcohol-related liver disease: A retrospective study. Williams T.J., Palmer A.J., Connor J.P., Holtmann G., Clark P.J., p. 2682-2690.
- Discontinuation of medications for alcohol use disorder in the United States: Patient, prescriber and medication predictors. Busch A.B., Hodgkin D., Kennedy-Hendricks A., Ritter G.A., Uscher-Pines L., Horgan C.M., et al., p. 2691-2700.
- Optimizing outpatient pharmacologic treatment for veterans with alcohol use disorder using an academic detailing approach for primary care providers in the United States Department of Veterans Affairs: A retrospective quasi-experimental study. Bounthavong M., Lau M.K., Popish S.J., Gray J., Chen A., Graham R., et al., p. 2701-2712.
- A cross-sectional and prospective examination of alcohol use and misuse among adult twin and sibling pairs discordant for neighborhood socio-economic disadvantage. Slutske W.S., Baker T.B., Piasecki T.M., p. 2713-2724.
- Financial incentives for maintaining postpartum smoking abstinence: 3-4-year follow-up of the Financial Incentives for Prevention of Postpartum Return to Smoking (FIPPS) randomised controlled trial. Ussher M., Best C., Lewis S., Bauld L., McKell J., Orton S., et al., p. 2725-2734.
- The Cannabis Research Image Database (CRESIDA): A standardized and validated image set for studying cannabis cue reactivity. Cousijn J., Kroon E., Suo C., Freeman T.P., Hindocha C., Quinones-Valera M., et al., p. 2735-2746.
- Cannabis consumer responses to the concept of standard THC units. Pawson M., Vuolo M., Kelly B.C., p. 2747-2756.
- The role of perceived access to cannabis in the association between friends who use cannabis and adolescent initiation: A longitudinal analysis from the Canadian COMPASS study. Sylvestre M.P., Boulanger L., Pelekanakis A., Naja M., Dubé G., Doré I., et al., p. 2757-2767.
- Change of substance-related hospitalisation in adolescents after cannabis legalisation in Thailand in 2022. Puetpaiboon S., Rajborirug S., Nakhonsri V., Ngamphiw C., Khunkham P., Tongsima S., et al., p. 2768-2779.
- E-cigarette and cannabis use and co-use patterns and dependence trajectories among young adults in the United States. Pokhrel P., Phillips K.T., Phillips M.M., Kawamoto C.T., Herzog T.A., p. 2780-2793.
- Comparative effectiveness of alternative times to opioid agonist treatment taper initiation on taper completion and all-cause mortality among people with opioid use disorder: A retrospective population-based target trial emulation study in British Columbia, Canada, 2010-2020. Yan R., Min J.E., Kurz M., Seaman S.R., Bach P., Greenland S., et al., p. 2794-2806.
- Collaborative care intervention for risky opioid use among primary care patients: The STOP randomized clinical trial. McNeely J., Subramaniam G.A., Stone R., Mazel S., Appleton N., Rostam-Abadi Y., et al., p. 2807-2821.
- Trends in new psychoactive substance poisonings in the Netherlands: A 14-year retrospective analysis (2012-2025). Nugteren-van Lonkhuyzen J.J., van den Hengel-Koot I.S., Hunault C.C., de Lange D.W., van Riel A., Hondebrink L., p. 2822-2832.
- A latent class analysis of clinical complexity: Secondary analysis of the collaboration leading to addiction treatment and recovery from other stresses (CLARO) randomized trial. Schuler M.S., Weir R., McCullough C.M., Hindmarch G.M., Griffin B.A., Becker K., et al., p. 2833-2844.
- Alcohol-free and low-alcohol beverage consumption and concurrent and subsequent alcohol outcomes among young adults. Mann S., Siconolfi D., Rodriguez A., Seelam R., Pedersen E.R., Dunbar M., et al., p. 2845-2851.
- The United Kingdom's Tobacco and Vapes Act 2026 - A landmark in tobacco control, but a missed opportunity for product clarity. Cox S., Notley C., West R., p. 2852-2853.